Dr. Bradley J. Martin
Managing Director, Fast Forward Medical Innovation
Dr. Bradley J. Martin is the managing director of Fast Forward Medical Innovation at the University of Michigan Medical School, with 15-plus years of experience in the development of drugs and biologics, and a particular expertise in preclinical development and translational research in the field of cardiovascular physiology and regenerative medicine.
Much of Martin’s career has focused on the development of stem cell therapies for the treatment of myocardial infarction and heart failure. He has considerable experience in leading cross-functional project teams, and has transitioned therapies from product concept through preclinical development, investigational new drug approval and eventual clinical trial.
Prior to leading MTRAC, Martin served as a mentor in residence for the U-M Tech Transfer Office, was the director of Product Development at Aastrom Biosciences, and the director of Cardiac Research at Osiris Therapeutics Inc. He also spent several years as a principal scientist with Pfizer’s Esperion Division, studying the anti-atherosclerotic properties of ApoA-I Milano, and other novel peptides.
He received his Ph.D. in physiology in 1993 from the University of Michigan, and completed post-doctoral fellowships in the departments of Cardiothoracic Surgery and Physiology at the University of Wisconsin.